NS
Naman Shripal Katariya
About Naman Shripal Katariya
Data last updated:
Naman Shripal Katariya is a Director at Narix Pharmaceuticals Private Limited (since 2022) and Designated Partner at O2 Global Ventures Llp (since 2022). The companies operate in Agriculture and Business Services. The largest current company by reported revenue is Narix Pharmaceuticals Private Limited at ₹1.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Narix Pharmaceuticals Private Limited U51220MH2022PTC393629 | Director | 16 Nov 2022 | 2022 | ₹1.26 Cr (FY 2025) | Active |
| O2 Global Ventures Llp AAV-9745 | Designated Partner | 31 Mar 2022 | 2021 | Active |
Board colleagues of Naman Shripal Katariya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shripal Lalchand Katariya | 09074209 | Narix Pharmaceuticals Private Limited , O2 Global Ventures Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naman Shripal Katariya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naman Shripal Katariya
Naman Shripal Katariya currently holds 2 directorships: Narix Pharmaceuticals Private Limited (Director, since 16 Nov 2022, revenue ₹1.26 Cr (FY 2025)); O2 Global Ventures Llp (Designated Partner, since 31 Mar 2022).
Naman Shripal Katariya was first appointed on 31 Mar 2022 as Designated Partner at O2 Global Ventures Llp.
The current boards of Naman Shripal Katariya's companies include Shripal Lalchand Katariya (Narix Pharmaceuticals Private Limited).